We are live on
!
Find out more
EC
Engaged Capital Portfolio holdings
AUM
$303M
1-Year Est. Return
2.09%
This Fund
S&P 500
This Quarter
Est. Return
+10.53%
1 Year Est. Return
-2.09%
3 Year Est. Return
+16.33%
5 Year Est. Return
+36.28%
10 Year Est. Return
+434.46%
AUM
$795M
AUM Growth
+$58M
(+7.9%)
Cap. Flow
+$14.5M
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
95.36%
Holding
19
New
4
Increased
6
Reduced
1
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apogee Enterprises
APOG
|
+$21.1M |
| 2 |
Anika Therapeutics
ANIK
|
+$10.8M |
| 3 |
Universal Electronics
UEIC
|
+$9.45M |
| 4 |
Babcock & Wilcox
BW
|
+$9.22M |
| 5 |
Benchmark Electronics
BHE
|
+$7.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FNSR
Finisar Corp
FNSR
|
+$40.1M |
| 2 |
Magnachip Semiconductor
MX
|
+$11.3M |
| 3 |
CCRN
Cross Country Healthcare
CCRN
|
+$3.39M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$3.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 51.35% |
| 2 | Technology | 26.51% |
| 3 | Industrials | 14.76% |
| 4 | Consumer Discretionary | 4.28% |
| 5 | Healthcare | 1.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Hain Celestial
HAIN
$47.8M
| $350M | 44.1% |
11,761,242
| – | – |
|
2
Upbound Group
UPBD
$1.19B
| $132M | 16.64% |
8,983,609
| – | – |
|
|
3
Apogee Enterprises
APOG
$850M
| $71.8M | 9.04% |
1,491,020
+492,086
| +49% | +$21.1M |
|
|
STKL
4
DELISTED
SunOpta
STKL
| $57.6M | 7.25% |
6,856,907
+100,000
| +1% | +$756K |
|
|
5
Benchmark Electronics
BHE
$2.91B
| $39.8M | 5.01% |
1,366,874
+274,164
| +25% | +$7.87M |
|
|
TIVO
6
DELISTED
Tivo Inc
TIVO
| $34M | 4.27% |
2,525,000
| – | – |
|
|
JMBA
7
DELISTED
Jamba, Inc.
JMBA
| $30.2M | 3.8% |
2,834,002
| – | – |
|
8
Celestica
CLS
$35.1B
| $19.6M | 2.47% |
1,652,439
| – | – |
|
|
9
Babcock & Wilcox
BW
$1.43B
| $11.5M | 1.45% |
482,854
+347,021
| +255% | +$9.22M |
|
10
NCR Voyix
VYX
$1.06B
| $10.7M | 1.34% |
579,952
+186,871
| +48% | +$3.53M |
|
|
PETX
11
DELISTED
Aratana Therapeutics, Inc.
PETX
| $10.2M | 1.28% |
2,400,000
+400,000
| +20% | +$2.02M |
|
|
12
Anika Therapeutics
ANIK
$199M
| $8.4M | 1.06% |
+262,547
| New | +$10.8M |
|
|
13
Universal Electronics
UEIC
$57.2M
| $8.32M | 1.05% |
+251,676
| New | +$9.45M |
|
14
Casey's General Stores
CASY
$31.9B
| $3.85M | 0.48% |
+36,672
| New | +$3.71M |
|
15
Groupon
GRPN
$980M
| $3.73M | 0.47% |
+43,406
| New | +$4.03M |
|
|
CCRN
16
DELISTED
Cross Country Healthcare
CCRN
| $2.34M | 0.29% |
207,680
-283,989
| -58% | -$3.39M |
|
|
17
iShares Russell 2000 ETF
IWM
$79.8B
| – | – |
-21,000
| Closed | -$3.19M |
|
|
18
Magnachip Semiconductor
MX
$128M
| – | – |
-1,181,225
| Closed | -$11.3M |
|
|
FNSR
19
DELISTED
Finisar Corp
FNSR
| – | – |
-2,538,126
| Closed | -$40.1M |
|
Similar funds
ECAM
TC
BPH
BCC
BKA
SF
AFO
OWM
Engaged Capital's Q2 2018 Portfolio in Review
As of Q2 2018, Engaged Capital held 19 positions worth $795M, up 7.9% from $737M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Engaged Capital's Q2 2018 filing shows 4 new, 6 increased, 1 reduced and 3 closed positions. Its largest new stake was Anika Therapeutics: 262,547 shares worth $8.4M. The largest sale was Finisar Corp, an estimated $40.1M.
By sector, the portfolio is most concentrated in Consumer Staples at 51% of assets, down from 58% a quarter earlier, followed by Technology and Industrials.
- Engaged Capital's largest Q2 2018 buy was Anika Therapeutics: 262,547 shares worth $8.4M.
- Engaged Capital added most to Apogee Enterprises in Q2 2018, an estimated $21.1M increase.
- Engaged Capital's biggest Q2 2018 reduction was Cross Country Healthcare, cutting an estimated $3.39M.
- Engaged Capital fully exited Finisar Corp in Q2 2018, selling an estimated $40.1M.
- Engaged Capital's ten largest holdings make up 95% of its $795M portfolio in Q2 2018.
- Engaged Capital opened 4 new positions and closed 3 in Q2 2018.
- Engaged Capital's portfolio value rose 7.9% quarter-over-quarter to $795M.
Based on Engaged Capital's 13F filing for Q2 2018, filed 14 Aug 2018.